在季度收益报告中,Nkarta 披露了其两个临床同种异体 CAR-NK 细胞治...查看全文
Nkarta(NKTX)03-29 07:35
$Nkarta(NKTX)$ SC 13D/A [Amend] General statement of acquisition of beneficial ownership Accession Number: 0001072613-24-000355 Act: 34 Size: 287 KB 网页链接查看全文
Nkarta(NKTX)03-05 05:25
$Nkarta(NKTX)$ 144 Report of proposed sale of securities Accession Number: 0001950047-24-001740 Act: 33 Size: 5 KB 网页链接查看全文
Nkarta(NKTX)03-02 05:35
$Nkarta(NKTX)$ 144 Report of proposed sale of securities Accession Number: 0001950047-24-001668 Act: 33 Size: 5 KB 网页链接查看全文
Nkarta(NKTX)04-06 00:25
$Nkarta(NKTX)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0001086364-24-007417 Act: 34 Size: 12 KB 网页链接查看全文
Nkarta(NKTX)03-22 04:25
$Nkarta(NKTX)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0000950170-24-034710 Act: 34 Size: 346 KB 网页链接查看全文
Nkarta(NKTX)04-16 05:15
$Nkarta(NKTX)$ PRE 14A Other preliminary proxy statements Accession Number: 0001140361-24-019897 Act: 34 Size: 4 MB 网页链接查看全文
Nkarta(NKTX)03-02 05:35
$Nkarta(NKTX)$ 144 Report of proposed sale of securities Accession Number: 0001950047-24-001660 Act: 33 Size: 4 KB 网页链接查看全文
Nkarta(NKTX)03-06 05:35
$Nkarta(NKTX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-026001 Size: 12 KB 网页链接查看全文
Nkarta(NKTX)03-25 18:15
$Nkarta(NKTX)$ 8-K Current report, items 7.01, 8.01, and 9.01 Accession Number: 0000950170-24-035613 Act: 34 Size: 16 MB 网页链接查看全文
Spica2020-12-08 22:16
$Fate Therapeutics(FATE)$ 最近ASH会议,几家CAR-NK的公司都要上天了$Nkarta(NKTX)$ $Affimed(AFMD)$查看全文
蹊之美股生物医药2020-12-05 18:48
作者:蹊之
微信公众号:蹊之美股生物医药
/AlleyMazeResearch
主要公司:Nkarta (NASDAQ: NKTX)
投资要点
NKX101的靶点NKG2D,治疗血液系统恶性肿瘤和实体瘤,这个靶点为NK细胞完成天然免疫的主要作用方式,临床上第一个患者已经用药。和CD16靶点有所不同,CD16是通过mA...查看全文
美股滚雪球2020-11-02 17:02
$赛诺菲-安万特(SNY)$ 以3.08亿欧元收购Kiadis,后者是做Off-the-shelf NK cell therapies ,利好$Fate Therapeutics(FATE)$ $Nkarta(NKTX)$ $NantKwest(NK)查看全文
神圣的升值毁灭者2020-10-10 11:31
$Nkarta(NKTX)$ Q2 EPS of -$30.06 may not be comparable to consensus of -$4.18.。
RA Capital 披露 了其在Nkarta的17.2%股权查看全文
绿专资本集团2020-07-08 10:11
近日全球资本市场一片红火,各大市场均大涨,亚太资本市场强劲,欧洲股市表现良好,美股凭借良好基本面,道指收涨1.78%,标普500指数涨1.59%,纳指涨2.53%。
在火热行情的带动下,IPO市场已愈加活跃,本周美股迎来5只新股,其中2家来自中企:蓝城兄弟、趣活科技。
蓝城兄弟
上市时...查看全文
$Nkarta(NKTX)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0000950170-24-056980 Act: 34 Size: 6 MB 网页链接
$Nkarta(NKTX)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0000950170-24-056870 Act: 34 Size: 290 KB 网页链接
$Nkarta(NKTX)$ DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material Accession Number: 0001140361-24-022088 Act: 34 Size: 2 MB 网页链接
$Nkarta(NKTX)$ ARS Annual Report to Security Holders Accession Number: 0001140361-24-022091 Act: 34 Size: 2 MB 网页链接
$Nkarta(NKTX)$ DEF 14A Other definitive proxy statements Accession Number: 0001140361-24-022080 Act: 34 Size: 4 MB 网页链接
$Nkarta(NKTX)$ PRE 14A Other preliminary proxy statements Accession Number: 0001140361-24-019897 Act: 34 Size: 4 MB 网页链接
$Nkarta(NKTX)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0001086364-24-007417 Act: 34 Size: 12 KB 网页链接
$Nkarta(NKTX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-24-009447 Size: 15 KB 网页链接
$Nkarta(NKTX)$ SC 13D/A [Amend] General statement of acquisition of beneficial ownership Accession Number: 0001104659-24-041249 Act: 34 Size: 96 KB 网页链接
$Nkarta(NKTX)$ SC 13D/A [Amend] General statement of acquisition of beneficial ownership Accession Number: 0001104659-24-041147 Act: 34 Size: 68 KB 网页链接